Arg315
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Mono-methylation Site Page: > Arg315  -  CSDA (rat)

Site Information
GPNQPSArRGFRRPY   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 9300423

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 , 4 )
Disease tissue studied:
adrenal cancer ( 1 , 2 , 3 , 4 ) , pheochromocytoma ( 1 , 2 , 3 , 4 )
Relevant cell line - cell type - tissue:
PC-12 (chromaffin) ( 1 , 2 , 3 , 4 )

References 

1

Zhou J (2009) CST Curation Set: 6814; Year: 2009; Biosample/Treatment: cell line, PC-12/untreated; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

2

Zhou J (2009) CST Curation Set: 6816; Year: 2009; Biosample/Treatment: cell line, PC-12/NGF; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

3

Zhou J (2009) CST Curation Set: 6813; Year: 2009; Biosample/Treatment: cell line, PC-12/untreated; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

4

Zhou J (2009) CST Curation Set: 6815; Year: 2009; Biosample/Treatment: cell line, PC-12/NGF; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info